United Therapeutics's market cap is currently ―. The company's EPS TTM is $22.769; its P/E ratio is ―; United Therapeutics is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $6.58. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 748.90M	$ 714.90M	$ 677.70M	$ 614.70M	$ 609.40M
Gross Profit	$ 665.80M	$ 637.10M	$ 604.80M	$ 543.70M	$ 539.30M
EBIT	$ 388.60M	$ 355.30M	$ 411.90M	$ 310.50M	$ 351.80M
EBITDA	$ 407.70M	$ 374.00M	$ 426.90M	$ 324.20M	$ 365.10M
Net Income Common Stockholders	$ 309.10M	$ 289.70M	$ 306.60M	$ 217.10M	$ 267.60M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 3.33B	$ 2.97B	$ 2.71B	$ 2.99B	$ 2.88B
Total Assets	$ 7.12B	$ 6.72B	$ 6.50B	$ 7.17B	$ 7.02B
Total Debt	$ ―	$ 500.00M	$ 600.00M	$ 700.00M	$ 800.00M
Net Debt	$ ―	$ -2.47B	$ -2.11B	$ -2.29B	$ -2.08B
Total Liabilities	$ 1.02B	$ 1.03B	$ 1.16B	$ 1.18B	$ 1.31B
Stockholders Equity	$ 6.10B	$ 5.70B	$ 5.34B	$ 5.98B	$ 5.71B
Cash Flow	-
Free Cash Flow	$ 300.70M	$ 187.10M	$ 338.30M	$ 72.00M	$ 280.50M
Operating Cash Flow	$ 377.20M	$ 232.20M	$ 376.50M	$ 150.70M	$ 346.20M
Investing Cash Flow	$ -114.90M	$ -80.00M	$ 735.30M	$ 42.10M	$ -313.40M
Financing Cash Flow	$ -64.10M	$ -48.00M	$ -1.07B	$ -92.80M	$ 7.60M

Currency in USD

United Therapeutics Earnings and Revenue History

Income Statement >

United Therapeutics Debt to Assets

Balance Sheet >

United Therapeutics Cash Flow

Cash Flow >

United Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing